Metabolic Profile and Tissue Perfusion in Patients Undergoing Open Heart Surgery With Minimal Invasive Versus Conventional Extracorporeal Circulation
MiECC MET
Study of Metabolic Profile and Tissue Perfusion in Patients Undergoing Open Heart Surgery With Minimal Invasive Versus Conventional Extracorporeal Circulation. Randomized Study
1 other identifier
interventional
70
1 country
1
Brief Summary
The aim of the present study is to investigate the protective effect of minimal invasive versus the conventional extracorporeal circulation on tissue homeostasis as evidenced by the preservation of tissue metabolism and cerebral perfusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedFirst Submitted
Initial submission to the registry
August 12, 2025
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedApril 8, 2026
April 1, 2026
3 years
August 12, 2025
April 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tissue hypoperfusion severity
Area under the curve (AUC) where tissue oxygen delivery indexed (DO2i) remains below the critical value of 280 ml/min/m2.
During surgery, from initiation of cardiopulmonary bypass to weaning of cardiopulmonary bypass
Secondary Outcomes (11)
Perfusion ratio derangement
During surgery from initiation of extracorporeal circulation to weaning of extracorporeal circulation.
Cerebral hypoperfusion
During surgery, from initiation to weaning of extracorporeal circulation
Overall mortality
From surgery to 30 days postoperatively
Major adverse cardiac and cerebrovascular events
From surgery to 30 days postoperatively
Renal failure
From surgery to 30 days postoperatively
- +6 more secondary outcomes
Study Arms (2)
Minimal Invasive Extracorporeal Circulation (MiECC)
EXPERIMENTALPatients undergoing cardiac surgery with Minimal Invasive Extracorporeal Circulation
Conventional Cardiopulmonary Bypass (cCPB)
ACTIVE COMPARATORPatients undergoing cardiac surgery with conventional cardiopulmonary bypass
Interventions
Real-time tissue metabolism as indicated by oxygen delivery (DO2), oxygen consumption (VO2), oxygen extraction ratio (O2ER), CO2 consumption (VCO2), arterial and mixed venous saturation (SvO2)
Eligibility Criteria
You may qualify if:
- patients undergoing undergoing open heart surgery with accepted indications under extracorporeal circulation
You may not qualify if:
- need for emergency surgery
- surgery on the thoracic aorta
- severe co-morbities causing anemia, immunosuppression etc.
- immunocompromised patients
- inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiothoracic Department, Artistotle University of Thessaloniki School of Medicine
Thessaloniki, Greece
Related Publications (4)
Anastasiadis K, Antonitsis P, Asteriou C, Deliopoulos A, Argiriadou H. Modular minimally invasive extracorporeal circulation ensures perfusion safety and technical feasibility in cardiac surgery; a systematic review of the literature. Perfusion. 2022 Nov;37(8):852-862. doi: 10.1177/02676591211026514. Epub 2021 Jun 17.
PMID: 34137323BACKGROUNDAnastasiadis K, Antonitsis P, Deliopoulos A, Argiriadou H. Perfusion matters, and it will always matter in cardiac surgery. Perfusion. 2021 Oct;36(7):677-678. doi: 10.1177/02676591211025154. Epub 2021 Jun 19. No abstract available.
PMID: 34148398BACKGROUNDAngelini GD, Reeves BC, Culliford LA, Maishman R, Rogers CA, Anastasiadis K, Antonitsis P, Argiriadou H, Carrel T, Keller D, Liebold A, Ashkaniani F, El-Essawi A, Breitenbach I, Lloyd C, Bennett M, Cale A, Gunaydin S, Gunertem E, Oueida F, Yassin IM, Serrick C, Murkin JM, Rao V, Moscarelli M, Condello I, Punjabi P, Rajakaruna C, Deliopoulos A, Bone D, Lansdown W, Moorjani N, Dennis S. Conventional versus minimally invasive extra-corporeal circulation in patients undergoing cardiac surgery: A randomized controlled trial (COMICS). Perfusion. 2025 Apr;40(3):730-741. doi: 10.1177/02676591241258054. Epub 2024 Jun 4.
PMID: 38832503BACKGROUNDAntonitsis P, Argiriadou H, Gkiouliava A, Deliopoulos A, Mimikos S, Gilou S, Sarridou D, Voucharas C, Karapanagiotidis G, Anastasiadis K. The value of cerebral and somatic near-infrared spectroscopy within an integrated tissue perfusion monitoring strategy in cardiac surgery: A prospective pilot study. Perfusion. 2026 Jan;41(1):69-79. doi: 10.1177/02676591251340942. Epub 2025 May 8.
PMID: 40338150BACKGROUND
Study Officials
- STUDY CHAIR
Kyriakos Anastasiadis, MD, PhD, FETCS
Aristotle University Of Thessaloniki
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Cardiac Surgery
Study Record Dates
First Submitted
August 12, 2025
First Posted
April 8, 2026
Study Start
January 1, 2022
Primary Completion
December 31, 2024
Study Completion
January 31, 2025
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share